1. Home
  2. VISN vs ADMA Comparison

VISN vs ADMA Comparison

Compare VISN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VISN

Vistance Networks Inc. Common Stock

N/A

Current Price

$17.65

Market Cap

3.9B

Sector

Technology

ML Signal

N/A

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$16.81

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VISN
ADMA
Founded
1976
2004
Country
United States
United States
Employees
20000
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
VISN
ADMA
Price
$17.65
$16.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$28.50
AVG Volume (30 Days)
3.3M
2.4M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
N/A
$42,219,783.00
Revenue This Year
$37.12
$26.71
Revenue Next Year
$9.59
$21.78
P/E Ratio
$5.37
$25.72
Revenue Growth
N/A
43.85
52 Week Low
$16.50
$13.50
52 Week High
$19.91
$25.67

Technical Indicators

Market Signals
Indicator
VISN
ADMA
Relative Strength Index (RSI) 41.71 53.49
Support Level N/A $16.39
Resistance Level $19.38 $17.90
Average True Range (ATR) 0.85 0.82
MACD -0.17 0.07
Stochastic Oscillator 33.14 85.25

Price Performance

Historical Comparison
VISN
ADMA

About VISN Vistance Networks Inc. Common Stock

Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: